Glenmede Trust’s Cognizant CTSH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16.1M Buy
262,308
+46,575
+22% +$3.33M 0.08% 211
2025
Q4
$17.9M Buy
+215,733
New +$16.1M 0.08% 201
2025
Q1
$23.4M Sell
306,514
-4,111
-1% -$335K 0.13% 152
2024
Q4
$23.9M Buy
310,625
+5,756
+2% +$450K 0.12% 154
2024
Q3
$23.5M Buy
304,869
+8,680
+3% +$647K 0.11% 178
2024
Q2
$20.1M Sell
296,189
-19,001
-6% -$1.29M 0.1% 196
2024
Q1
$23.1M Sell
315,190
-6,116
-2% -$467K 0.12% 180
2023
Q4
$24.3M Buy
321,306
+175,768
+121% +$12.1M 0.13% 169
2023
Q3
$9.86M Sell
145,538
-222,305
-60% -$15.3M 0.06% 338
2023
Q2
$22.4M Sell
367,843
-564
-0.2% -$34.9K 0.13% 173
2023
Q1
$22.4M Sell
368,407
-84,150
-19% -$5.27M 0.13% 173
2022
Q4
$25.9M Buy
452,557
+44,768
+11% +$2.63M 0.15% 155
2022
Q3
$23.4M Buy
407,789
+12,026
+3% +$788K 0.15% 161
2022
Q2
$26.7M Sell
395,763
-5,758
-1% -$441K 0.16% 153
2022
Q1
$36M Buy
401,521
+9,150
+2% +$804K 0.18% 135
2021
Q4
$34.8M Sell
392,371
-163,900
-29% -$13.2M 0.17% 138
2021
Q3
$41.3M Sell
556,271
-46,597
-8% -$3.44M 0.21% 117
2021
Q2
$41.8M Sell
602,868
-264,249
-30% -$19.7M 0.22% 117
2021
Q1
$67.7M Sell
867,117
-30,991
-3% -$2.39M 0.37% 74
2020
Q4
$73.6M Buy
898,108
+306,343
+52% +$23.3M 0.4% 65
2020
Q3
$41.1M Sell
591,765
-31,519
-5% -$2.05M 0.25% 109
2020
Q2
$35.4M Sell
623,284
-94,915
-13% -$5.1M 0.22% 116
2020
Q1
$44.5M Hold
718,199
0.2% 139
2019
Q4
$44.5M Sell
718,199
-232,096
-24% -$14.3M 0.2% 139
2019
Q3
$57.3K Buy
950,295
+591,118
+165% +$37.4M 0.26% 106
2019
Q2
$22.8K Sell
359,177
-1,422,155
-80% -$93.3M 0.1% 279
2019
Q1
$129K Buy
1,781,332
+35,337
+2% +$2.47M 0.58% 35
2018
Q4
$111K Buy
1,745,995
+132,580
+8% +$9.22M 0.54% 40
2018
Q3
$124M Sell
1,613,415
-864,170
-35% -$67.6M 0.5% 36
2018
Q2
$196M Buy
2,477,585
+41,595
+2% +$3.27M 0.87% 10
2018
Q1
$173M Hold
2,435,990
0.72% 17
2017
Q4
$173M Sell
2,435,990
-1,602
-0.1% -$117K 0.72% 17
2017
Q3
$177M Buy
2,437,592
+130,090
+6% +$9.14M 0.78% 13
2017
Q2
$137M Hold
2,307,502
0.66% 17
2017
Q1
$137M Buy
2,307,502
+1,502,158
+187% +$86.4M 0.66% 17
2016
Q4
$45.1M Buy
805,344
+316,253
+65% +$16.9M 0.25% 114
2016
Q3
$23.3M Sell
489,091
-29,961
-6% -$1.7M 0.13% 262
2016
Q2
$29.7M Sell
519,052
-1,133,972
-69% -$68.5M 0.18% 194
2016
Q1
$104M Buy
1,653,024
+199,857
+14% +$11.6M 0.67% 19
2015
Q4
$87.2M Buy
1,453,167
+99,947
+7% +$6.44M 0.6% 26
2015
Q3
$84.7M Buy
1,353,220
+138,096
+11% +$8.67M 0.62% 20
2015
Q2
$74.2M Buy
1,215,124
+58,750
+5% +$3.69M 0.54% 28
2015
Q1
$72.1M Buy
1,156,374
+139,757
+14% +$8.24M 0.53% 31
2014
Q4
$53.5M Buy
1,016,617
+193,383
+23% +$9.66M 0.42% 44
2014
Q3
$36.9M Buy
823,234
+100,992
+14% +$4.75M 0.32% 69
2014
Q2
$35.3M Buy
722,242
+79,911
+12% +$3.89M 0.32% 67
2014
Q1
$32.5M Buy
642,331
+38,779
+6% +$1.94M 0.3% 70
2013
Q4
$30.5M Sell
603,552
-79,892
-12% -$3.64M 0.31% 65
2013
Q3
$28.1M Sell
683,444
-30,258
-4% -$1.12M 0.33% 67
2013
Q2
$22.4M Buy
+713,702
New +$23.7M 0.28% 75

Other funds holding CTSH

Glenmede Trust's CTSH Position: Q1 2026 in Review

Glenmede Trust increased its Cognizant (CTSH) stake by 22% in Q1 2026, buying an estimated $3.33M and bringing the position to 262,308 shares worth $16.1M. The position accounts for 0.08% of the portfolio, ranked #211.

Glenmede Trust first reported a position in CTSH in Q2 2013 and has held it in 50 quarters since. The position peaked at $196M in Q2 2018. 985 funds tracked by Wall St. Rank hold CTSH as of Q1 2026.

  • Glenmede Trust held 262,308 shares of Cognizant worth $16.1M as of Q1 2026.
  • Glenmede Trust bought 46,575 Cognizant shares in Q1 2026, an estimated $3.33M.
  • Cognizant made up 0.08% of Glenmede Trust's portfolio in Q1 2026, its #211 holding.
  • Glenmede Trust first reported a position in Cognizant in Q2 2013 and has held it in 50 quarters since.
  • Glenmede Trust's Cognizant position peaked at $196M in Q2 2018.
  • 985 funds tracked by Wall St. Rank held Cognizant as of Q1 2026.

Based on Glenmede Trust's 13F filing for Q1 2026, filed 26 May 2026.